Decreased glial activation in A2−/− OIR retina. by Subhadra P. Narayanan (347660)

Resveratrol treatment decreases SIRT1 and SIRT2 levels. by Mehtap Kilic Eren (591048)

Stx16 depleted MDCK cells show decreased E-cadherin at cell-cell junctions. by Jae-Joon Jung (139625)

Loss of Abl kinase function decreased endothelial barrier dysfunction <i>in</i><i>vitro</i>. by Elizabeth M. Chislock (499669)

Decreased osteoclast formation by LDH-A or LDH-B depletion. by Heejin Ahn (3173670)

Knockdown of NG2 by siRNA results in decreased viability and a reduction in PARP levels. by Frank Maus (792209)

Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial by José Tarcisio G. Carvalho (4217248)

“…In the clinical trial, thirty-two (32) dialysis patients with 25 vitamin D ≤ 20ng/mL were randomized to receive either supplementation of cholecalciferol 100,000 UI/week/3 months (16 patients) or placebo (16 patients). …”

GSH depletion leads to a strong decrease in SCF-dependent HIF-1α PHD activity in LAD2 cells. by Bernhard F. Gibbs (328262)

Stx16 depletion leads to decrease in E-cadherin levels and formation of multiple lumens in epithelial cysts. by Jae-Joon Jung (139625)

Demethylation of HPV16 LCR CpG sites decreases E6 and E7 expression. by Chunlin Zhang (663063)

“…<b>C)</b> E6 and <b>D)</b> E7 protein after demethylation of the CpG sites was detected by immunocytochemistry; E6 and E7 oncoproteins were distributed in the cytoplasm and nucleus of UM-SCC47 and CaSki cells with a strong staining intensity (×100, bar = 100 μm), and both the percentages and intensity of stained cells were clearly decreased after demethylation (×100, bar = 100 μm).…”

Decreased expression of Notch factors in HUVEC-HBVP cocultures after 16K hPRL treatment. by Ngoc-Quynh-Nhu Nguyen (340032)

Sulforaphane decreases IL-6, TNF-α, IL-17, and total IgG levels. by Su-Jin Moon (424173)

Microglia-conditioned medium decreases NPC viability. by Johanna Mäkelä (223358)

Translocation of EHEC-Hly to mitochondria results in cytosolic cytochrome c release and ΔΨ_m decrease. by Martina Bielaszewska (79970)

“…<p>(<b>A, B</b>) HBMEC (<b>A</b>) and Caco-2 cells (<b>B</b>) were incubated for the times indicated with EHEC-Hly-containing OMVs TA50 or 8033 (20 µg of OMV protein containing 100 ng of EHEC-Hly) or with corresponding protein amounts of EHEC-Hly-negative OMVs TA51 or 8033c or left untreated (control). …”

ALK2 AON-induced exon skipping decreased BMP signaling in 2H11 endothelial cells. by SongTing Shi (430629)

(R+S) and (R)-albuterol decrease NF-κB activity by Marcela A Ferrada (41716)

“…After transfection, (R)-albuterol (R), (S)-albuterol (S), or racemic albuterol (R+ S) were added to cells pre-activated with (ConA, 5 μg/ml) and (PMA, 100 ng/ml) (CP) and then treated with (R)-, (S)-, or (R+S)-albuterol (Fig. 6). …”

(R)-albuterol decreases cytokine protein levels in activated T cells by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”

(R)-albuterol decreases cytokine levels in activated murine splenocytes by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol (R), (S)-albuterol (S) or racemic albuterol (R + S) at a dose (10M) were added to murine splenocytes pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP), (Fig 3 A, B). …”

Effect of IκK-16 on cytokine production. by Norman James Galbraith (4436560)

Expression and stability of EspA are decreased in the absence of <i>escA.</i> by Ching-Nan Lin (508587)